Search Prime Grants

H79TI084545

Project Grant

Overview

Grant Description
MS-CORP (Mississippi's Comprehensive Opioid-Overdose Reduction Program) aims to strengthen Mississippi's opioid use continuum of care by expanding and enhancing EMS-based naloxone access for persons experiencing a suspected opioid overdose. A three-pronged, team-based approach to care will incorporate community-based care management (CBCM) teams consisting of a DOJ COSSAP-funded Peer Support Specialist (PRSS), a MS-CORP-funded Social Worker (LCSW), EMS service providers, and the Mississippi Public Health Institute. This collaborative, coordinated continuum of care approach will utilize evidence-based interventions that establish client-provider partnerships and equitable access for the whole population.

MS-CORP providers will make naloxone more widely available for emergency reversal of known or suspected opioid overdose in prioritized high-need, low-capacity rural Mississippi counties. The CBCM will provide follow-up care for patients receiving naloxone to provide addiction and treatment education, facilitate warm hand-offs to treatment providers including behavioral/mental and physical health services, and motivate clients to sustain engagement. The CBCM will facilitate recovery by assisting clients in securing stable housing and employment and reestablishing interpersonal relationships.

MS-CORP intends to achieve the following objectives:
1. Increase naloxone access through service providers for individuals suffering from a nonfatal opioid overdose and facilitate the referral process to connect individuals receiving opioid overdose reversal drugs to services.
2. Increase awareness of opioid use disorder, naloxone distribution, and safety around fentanyl, carfentanil, and other dangerous licit and illicit drugs.
3. Establish and implement evaluation processes to assess project effectiveness and ensure sustainable gains.

The objectives for MS-CORP are as follows:
Objective 1: By the end of year 1, foster naloxone-focused infrastructure enhancement at state and community levels through the establishment of MS-CORP key positions (Project Director and Project Evaluator), an Advisory Council, a coordinated care approach, and a naloxone-specific training curriculum.
Objective 2: Enhance service providers' knowledge of opioid overdose response within the six predetermined geographic regions, with emphasis on culturally responsive implementation designed to address treatment needs of focal population, by offering a minimum of four naloxone training sessions among service providers annually, ultimately reaching a minimum of 50 service providers during year 1.
Objective 3.1: By the end of year 1, conduct a rigorous evaluation to ensure compliance with all data collection and reporting requirements while fostering naloxone distribution-related quality improvements, as indicated by the completion of required data collection tools and dissemination of related reports.
Objective 3.2: By the end of quarter 1 of year 1 (M4-PY1), complete all required grant management activities effectively, as indicated by documented and executed implementation, quality improvement, and sustainability plans, meeting attendance, and partnership agreements.

MS-CORP evaluators will collect and report performance data using the GPRA tool and other instruments. It is anticipated that the number of naloxone kits provided to individuals receiving services will reach 600 in year 1, 1,200 in year 2, 1,800 in year 3, and a total of 5,400 across all funded years.
Funding Goals
SAMHSA WAS GIVEN THE AUTHORITY TO ADDRESS PRIORITY SUBSTANCE ABUSE TREATMENT, PREVENTION AND MENTAL HEALTH NEEDS OF REGIONAL AND NATIONAL SIGNIFICANCE THROUGH ASSISTANCE (GRANTS AND COOPERATIVE AGREEMENTS) TO STATES, POLITICAL SUBDIVISIONS OF STATES, INDIAN TRIBES AND TRIBAL ORGANIZATIONS, AND OTHER PUBLIC OR NONPROFIT PRIVATE ENTITIES. UNDER THESE SECTIONS, CSAT, CMHS AND CSAP SEEK TO EXPAND THE AVAILABILITY OF EFFECTIVE SUBSTANCE ABUSE TREATMENT AND RECOVERY SERVICES AVAILABLE TO AMERICANS TO IMPROVE THE LIVES OF THOSE AFFECTED BY ALCOHOL AND DRUG ADDITIONS, AND TO REDUCE THE IMPACT OF ALCOHOL AND DRUG ABUSE ON INDIVIDUALS, FAMILIES, COMMUNITIES AND SOCIETIES AND TO ADDRESS PRIORITY MENTAL HEALTH NEEDS OF REGIONAL AND NATIONAL SIGNIFICANCE AND ASSIST CHILDREN IN DEALING WITH VIOLENCE AND TRAUMATIC EVENTS THROUGH BY FUNDING GRANT AND COOPERATIVE AGREEMENT PROJECTS. GRANTS AND COOPERATIVE AGREEMENTS MAY BE FOR (1) KNOWLEDGE AND DEVELOPMENT AND APPLICATION PROJECTS FOR TREATMENT AND REHABILITATION AND THE CONDUCT OR SUPPORT OF EVALUATIONS OF SUCH PROJECTS, (2) TRAINING AND TECHNICAL ASSISTANCE, (3) TARGETED CAPACITY RESPONSE PROGRAMS (4) SYSTEMS CHANGE GRANTS INCLUDING STATEWIDE FAMILY NETWORK GRANTS AND CLIENT-ORIENTED AND CONSUMER RUN SELF-HELP ACTIVITIES AND (5) PROGRAMS TO FOSTER HEALTH AND DEVELOPMENT OF CHILDREN, (6) COORDINATION AND INTEGRATION OF PRIMARY CARE SERVICES INTO PUBLICLY-FUNDED COMMUNITY MENTAL HEALTH CENTERS AND OTHER COMMUNITY-BASED BEHAVIORAL HEALTH SETTINGS
Place of Performance
Mississippi United States
Geographic Scope
State-Wide
Analysis Notes
Amendment Since initial award the total obligations have increased 300% from $800,000 to $3,200,000.
Mississippi State Department Of Health was awarded Naloxone Access Program for Opioid Overdose Reversal in Mississippi Project Grant H79TI084545 worth $3,200,000 from the Division of Grants Management in September 2021 with work to be completed primarily in Mississippi United States. The grant has a duration of 4 years and was awarded through assistance program 93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance. The Project Grant was awarded through grant opportunity First Responders-Comprehensive Addiction and Recovery Act Grants.

Status
(Ongoing)

Last Modified 2/5/25

Period of Performance
9/30/21
Start Date
9/29/25
End Date
97.0% Complete

Funding Split
$3.2M
Federal Obligation
$0.0
Non-Federal Obligation
$3.2M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to H79TI084545

Subgrant Awards

Disclosed subgrants for H79TI084545

Transaction History

Modifications to H79TI084545

Additional Detail

Award ID FAIN
H79TI084545
SAI Number
H79TI084545-2839203190
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75SAMH SAMHSA DIVISION OF GRANTS MANAGEMENT
Funding Office
75MT00 SAMHSA CENTER FOR SUBSTANCE ABUSE TREATMENT
Awardee UEI
GHELM9ULN8A1
Awardee CAGE
1B5U3
Performance District
MS-90
Senators
Roger Wicker
Cindy Hyde-Smith

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Substance Abuse Treatment, Substance Abuse and Mental Health Administration, Health and Human Services (075-1364) Health care services Grants, subsidies, and contributions (41.0) $1,600,000 100%
Modified: 2/5/25